期刊文献+

慢性肾脏病-矿物质和骨代谢异常与能量代谢 被引量:2

Chronic kidney disease-mineral and bone disorder and energy metabolism
下载PDF
导出
摘要 慢性肾脏病-矿物质和骨代谢异常(CKD-MBD)的危害近年来日益受到重视,除传统致病因素外,能量代谢因子瘦素、胰岛素、脂联素等也参与了CKD-MBD的发生与发展。高瘦素血症可以通过直接和间接途径影响骨重塑;CKD患者伴有糖尿病会损伤成骨细胞功能,易发生低甲状旁腺素(PTH)动力不良性骨病;CKD患者脂联素水平升高的意义也与生理状态不同,可作为骨病严重程度的标记物。CKD-MBD与能量代谢的相互影响仍需要更多的基础和临床研究阐明,针对其分子机制的干预可能会给CKD-MBD带来新的治疗手段。本文将就CKD-MBD与能量代谢的相互影响作一综述。 The damage of chronic kidney disease-mineral and bone disorder (CKD-MBD) has drawn increasing attention in recent years. In addition to traditional pathogenic factors, energy regulatory factors such as leptin, insulin, and adiponeetin also participate in the development and progression of CKD-MBD. Hyperleptinaemia can directly or indirectly affect bone formation. CKD patients with diabetes have injured osteoblast function and are liable to have low dynamic osteopathy with low parathyroid hormone (PTH). Adiponectin is increased in CKD patients, which can be used as a marker for severity of osteopathy. More basic and clinical researches are needed to elucidate the mutual influence between CKD-MBD and energy metabolism. The interventions targeting molecular mechanisms may bring new treatments to CKD-MBD. This paper reviewed the mutual influence of CKD-MBD and energy metabolism.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2013年第8期899-903,共5页 Academic Journal of Second Military Medical University
基金 上海市浦江人才计划(12PJ1403300) 上海市科委重大基础研究项目(12DJ1400300)~~
关键词 肾疾病 肾性骨病 能量代谢 瘦素 kidney diseases renal osteopathy energy metabolism leptin
  • 相关文献

参考文献40

  • 1Moorthi R N, Moe S M. Recent advances in the nonin?vasive diagnosis of renal osteodystrophy[J]. Kidney Int,2013,26.[Epub ahead of pririt]. 被引量:1
  • 2Kalbacher E, Koppe L, Zarrouki B, Pillon NJ, Fouque D,Soulage C 0. Human uremic plasma and not urea in?duces exuberant secretion of leptin in 3T3-Ll adipo?cytes[J].J Ren Nutr,2011,21:72-75. 被引量:1
  • 3Karsenty G, Kronenberg H M, Settembre C. Genetic control of bone formation[J]. Annu Rev Cell Dev Bioi, 2009,25:629-648. 被引量:1
  • 4Yadav V Kv Oury F,Suda N,Liu Z W,Gao X B,Con?favreux C, et al. A serotonin-dependent mechanism ex?plains the leptin regulation of bone mass, appetite, and energy expenditure[J]. Cell, 2009,138: 976-989. 被引量:1
  • 5Ducy P, Amling M, Takeda S, Priemel M, Schilling A F, Beil F T, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass[J]. Cell, 2000,100: 197-207. 被引量:1
  • 6Shankar A,Syamala S,XiaoJ,Muntner P. Relationship between plasma leptin level and chronic kidney disease [n IntJ Nephrol,2012,2012:269532. 被引量:1
  • 7Tsuji K, Maeda T, Kawane T, Matsunuma A, Horiuchi N. Leptin stimulates fibroblast growth factor 23 expres?sion in bone and suppresses renal Lalpha , 25-di?hydroxyvitamin D3 synthesis in leptin-deficient mice[J].J Bone Miner Res,2010,25:1711-1723. 被引量:1
  • 8Grethen E, Hill K M,Jones R, Cacucci B M, Gupta C E, Acton A,et al. Serum leptin , parathyroid hormone, 1 ,25-di?hydroxyvitamin D, fibroblast growth factor 23, bone alka?line phosphatase, and sclerostin relationships in obesity[J].J Clin Endocrinol Metab,2012,97:1655-1662. 被引量:1
  • 9Kanda E, Yoshida M, Sasaki S. Applicability of fibro?blast growth factor 23 for evaluation of risk of vertebral fracture and chronic kidney disease-mineral bone disease in elderly chronic kidney disease patients[J]. BMC Nephrol , 2012,13: 122. 被引量:1
  • 10Gauthier-Bastien A, Ung R V .Lariviere R,Mac-Way F, Lebel M, Agharazii M. Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease[J]. Clin Exp Hypertens , 2013,20.[Epub ahead of print]. 被引量:1

二级参考文献11

共引文献4

同被引文献21

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部